Skip to main content
. 2019 Jun 28;20(13):3162. doi: 10.3390/ijms20133162
UCB urothelial carcinoma of the bladder
UTUC upper tract urothelial carcinoma
AA aristolochic acid
ESRD end-stage renal disease
UC urothelial carcinoma
RNU radical nephron-ureterectomy
ICI immune checkpoint inhibitor
PD1 programmed cell death protein 1
CTLA4 cytotoxic T-lymphocyte protein 4
FDA Food and Drug Administration
ICC investigator-choice chemotherapy